Cargando…

p-STAT3 expression in breast cancer correlates negatively with tumor size and HER2 status

Although some studies have reported the expression and clinical significance of phosphorylated signal transducer and activator of transcription 3 (p-STAT3) in breast cancer tissues, it is still controversial whether p-STAT3 play a role in promoting or suppressing cancer. Here, we used immunohistoche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan, Wang, Qian, Tang, Chih-Hsin, Chen, Hua-Dong, Hu, Gui-Nv, Shao, Jun-Kang, Dong, Xiao-Fang, Jin, Lu-Lu, Wang, Chao-Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969220/ https://www.ncbi.nlm.nih.gov/pubmed/33725911 http://dx.doi.org/10.1097/MD.0000000000025124

Ejemplares similares

High Plasma Fibrinogen is Correlated With Poor Response to Trastuzumab Treatment in HER2 Positive Breast Cancer
por: Liu, Yu-Lin, et al.
Publicado: (2015)

Musashi1 expression is negatively correlated with numb expression in brain metastases
por: Dong, Yalan, et al.
Publicado: (2020)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies
por: Zhang, Qingyu, et al.
Publicado: (2016)

KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China
por: Lian, Shen-Yi, et al.
Publicado: (2023)

Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy
por: Luo, Hua-Chun, et al.
Publicado: (2016)

Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
por: Chen, Hai-long, et al.
Publicado: (2021)

A Qualitative Study Comparing the Assay Performance Characteristics Between the 2007 and the 2013 American Society for Clinical Oncology and College of American Pathologists HER2 Scoring Methods in Mucinous Epithelial Ovarian Cancer
por: Chen, Chi-Kuan, et al.
Publicado: (2014)

Efficacy and safety of treatment with or without pertuzumab for HER2-positive breast cancer: A meta-analysis
por: Chen, Xuan, et al.
Publicado: (2023)

Poziotinib in non-small-cell lung cancer patients with HER2 exon 20 mutations: A pooled analysis of randomized clinical trials
por: Wang, Bi-Cheng, et al.
Publicado: (2022)

Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis
por: Wang, Hong-Bo, et al.
Publicado: (2017)

Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer
por: Wang, Di, et al.
Publicado: (2016)

Gender-Based Impact of Epidermal Growth Factor Receptor Mutation in Patients With Nonsmall Cell Lung Cancer and Previous Tuberculosis
por: Chang, Chia-Hao, et al.
Publicado: (2015)

Sera total oxidant/antioxidant status in lung cancer patients
por: Xiang, Miao, et al.
Publicado: (2019)

Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis
por: Bai, Long, et al.
Publicado: (2016)

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

6 versus 12 months of adjuvant trastuzumab in HER2+ early breast cancer: A systematic review and meta-analysis
por: Wang, Bi-Cheng, et al.
Publicado: (2021)

Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review
por: Lin, Li, et al.
Publicado: (2017)

STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma
por: Zeng, Tao, et al.
Publicado: (2023)

The impact of miR-9 in osteosarcoma: A study based on meta-analysis, TCGA data, and bioinformatics analysis
por: Wu, Fengfeng, et al.
Publicado: (2020)

Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor–mutated lung adenocarcinoma
por: Li, Chi-Cheng, et al.
Publicado: (2020)

The role of claudin 18.2 and HER-2 in pancreatic cancer outcomes
por: Kayikcioglu, Erkan, et al.
Publicado: (2023)

Downregulated METTL14 Expression Correlates with Breast Cancer Tumor Grade and Molecular Classification
por: Dong, Xiao-Fang, et al.
Publicado: (2020)

Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status
por: Chen, Jianxin, et al.
Publicado: (2019)

Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers
por: Chen, Yanglong, et al.
Publicado: (2019)

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis
por: Lin, En-Kwang, et al.
Publicado: (2016)

Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma
por: Isaka, Tetsuya, et al.
Publicado: (2015)

Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study
por: Shokouh, Taghipour Zahir, et al.
Publicado: (2015)

ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma
por: Lin, Chao, et al.
Publicado: (2016)

Correlation analysis and clinical significance of CA125, HE4, DDI, and FDP in type II epithelial ovarian cancer
por: Qiao, Li, et al.
Publicado: (2020)

Trends of triple negative breast cancer research (2007–2015): A bibliometric study
por: Wang, Yiran, et al.
Publicado: (2016)

Prognostic value of tumor size in thymic epithelial tumors: A systematic review and meta-analysis
por: Shao, Yifeng, et al.
Publicado: (2022)

Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
por: Ma, Fei, et al.
Publicado: (2017)

Association of hormone receptor status with cardiovascular disease mortality in 399,209 patients with stage I to III breast cancer: A population-based study
por: Lai, Zhihua, et al.
Publicado: (2022)

A nomogram for predicting the likelihood of lymph node metastasis in early gastric signet ring cell carcinoma: A single center retrospective analysis with external validation
por: Guo, Chun Guang, et al.
Publicado: (2016)

GPR137 is a promising novel bio-marker for the prognosis of bladder cancer patients
por: Lu, Jianlei, et al.
Publicado: (2019)

Cancer studies based on secondary data analysis of the Taiwan's National Health Insurance Research Database: A computational text analysis and visualization study
por: Chiang, Jui-Kun, et al.
Publicado: (2017)

The efficacy and safety of neoadjuvant buparlisib for breast cancer: A meta-analysis of randomized controlled studies
por: Luo, Qian, et al.
Publicado: (2019)

Treating the primary in low burden metastatic prostate cancer: Where do we stand?
por: Luo, Hua-Chun, et al.
Publicado: (2020)

Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer: A retrospective analysis in a real-world setting
por: Leng, Jiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3k819abceg6rhs5ta147odneks